Application no. and date | 10781527.6 (espacenet) (Federated) (European Patent Register), 20101129 | Patent/reg. no. and date | DK/EP 2506844, 20171220 | Publication date | 20121010 | Priority no. and date | GB 0921075, 20091201 | EP pub. no. and date |
EP 2506844 20121010 | Effective date | | Applicant/owner | Glaxo Group Limited, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | Applicant ref. no. | 161187 | Inventor | BRUCE, Mark, GlaxoSmithKline Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY, GB, BAKER, Darrell, GlaxoSmithKline Ironbridge Road
Uxbridge Middlesex UB11 1BS, GB, CRATER, Glenn, GlaxoSmithKline Five Moore Drive P O Box 13398 Research Triangle Park
North Carolina 27709-3398, US, NOGA, Brian, c/o GlaxoSmithKline Five Moore Drive P O Box 13398 Research Triangle Park
North Carolina 27709-3398, US, THOMAS, Marian, GlaxoSmithKline Park Road
Ware Hertfordshire SG12 0DJ, GB, WIRE, Patrick, GlaxoSmithKline Five Moore Drive P O Box 13398 Research Triangle Park
North Carolina 27709-3398, US | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/138 (2006.01) , A61K 31/439 (2006.01) , A61K 45/06 (2006.01) , A61P 11/06 (2006.01) , A61P 11/08 (2006.01) | Title | Kombinationer af en muscarinreceptorantagonist og en beta-2-adrenoreceptoragonist | Int. application no. | EP2010068429 | Int. publication no. | WO2011067212 | Related patent (certificate) | CA 2018 00023 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|